Skip to main content
BC Innovations
Feature Story

All change at King's Cross

How The Crick wants to kick-start translation in the U.K.

By C. Simone Fishburn, Editor, BioCentury Innovations

Despite the U.K.'s long record of producing world-class medical science, the country hasn't had the success of Boston or the Bay Area in converting that into products or companies that can drive a robust biotech ecosystem. Six of London's major research institutes have now come together with an investment of about £650 million ($937 million) to form the Francis Crick Institute - a biomedical discovery institute focused on translational science.

BioCentury sat down with David Roblin, COO and director of scientific translation at The Crick, who thinks the institute can be an agent of change, and wants it to become a major player in translational research that can help put U.K. science high on the list for investors. But he also sees the U.K. as part of a "European powerhouse of science" and says like most of the country's scientific leadership, in the "Brexit" debate about whether the country should withdraw from the EU, he favors remaining.

Read Article

Today's Biotech & Pharma News

  • THE DISTILLERY brings you this week's most essential scientific findings in therapeutics, distilled by Innovations editors from a weekly review of more than 400 papers in 41 of the highest-impact journals in the fields of biotechnology, the life sciences and chemistry. The Distillery goes beyond the abstracts to explain the commercial relevance of featured research, including licensing status and companies working in the field, where applicable.

    This week in therapeutics includes important research findings on targets and compounds, grouped first by disease class and then alphabetically by indication.

    This week in techniques includes findings about research tools, disease models and manufacturing processes that have the potential to enable or improve all stages of drug discovery and development.

Subscribe Now
Free Trial

Management Updates

There were no items published for this section in the most recent issue. Click more >> to read previously published items.

Preclinical Results

There were no items published for this section in the most recent issue. Click more >> to read previously published items.